Lista de obras -

A Diagnostic Score for Insulin Resistance in Nondiabetic Patients with Ischemic Stroke or Transient Ischemic Attack

artículo científico publicado en 2016

A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks.

artículo científico publicado en 2018

Achievement of Guideline-Recommended Weight Loss Among Patients With Ischemic Stroke and Obesity

scientific article published on 01 March 2019

Adherence reporting in randomized controlled trials

artículo científico

Altruism as a reason for participation in clinical trials was independently associated with adherence

artículo científico publicado en 2005

An Error in An Old Paper Illustrates the Need for Data/Code Archives - Author response

scientific article published on 20 November 2018

Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort

artículo científico publicado en 2020

Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus

artículo científico

Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum

artículo científico publicado en 2018

Clinical assessment of function among women with a recent cerebrovascular event: a self-reported versus performance-based measure

artículo científico publicado en 2002

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF

artículo científico publicado en 2020

Decline in physical performance among women with a recent transient ischemic attack or ischemic stroke: opportunities for functional preservation a report of the Women's Estrogen Stroke Trial

artículo científico publicado en 2005

Diabetes prevention and cardiovascular complications

scientific article published on 14 September 2019

Disagreement between students and preceptors regarding the value of teaching behaviors for ambulatory care settings

artículo científico publicado en 2008

Distance from Home to Research Center: A Barrier to In-Person Visits but Not Treatment Adherence in a Stroke Trial.

artículo científico publicado en 2018

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy ⬇️

artículo científico publicado en 2020

Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial

artículo científico publicado en 2017

Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial

artículo científico publicado en 2003

Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes

artículo científico publicado en 2020

Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST).

artículo científico publicado en 2005

Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone

artículo científico publicado en 2018

Influence of race, clinical, and other socio-demographic features on trial participation

artículo científico publicado en 2003

Is It Time to Change the Type 2 Diabetes Treatment Paradigm? No! Metformin Should Remain the Foundation Therapy for Type 2 Diabetes

artículo científico publicado en 2017

Litigation seeking access to data from ongoing clinical trials: a threat to clinical research

artículo científico publicado en 2014

Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis

artículo científico publicado en 2006

Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable

artículo científico publicado en 2003

Major risk factors for intracerebral hemorrhage in the young are modifiable

artículo científico publicado en 2005

Medical students' assessment of education and training in women's health and in sex and gender differences

artículo científico publicado en 2008

Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular disease

artículo científico publicado en 2018

Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease

artículo científico publicado en 2016

Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).

artículo científico publicado en 2017

Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial

artículo científico publicado en 2019

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

artículo científico publicado en 2016

Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial

artículo científico publicado en 2016

Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial

artículo científico publicado en 2014

Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke

artículo científico publicado en 2003

Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke

artículo científico publicado en 2005

Reports of Lactic Acidosis Attributed to Metformin, 2015-2018

scientific article published on 09 October 2019

Response by Young et al to Letters Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".

artículo científico publicado en 2017

Response to Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015-2018. Diabetes Care 2020;43:244-246

scientific article published on 01 October 2020

Response to Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684-1692.

artículo científico publicado en 2017

Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial

artículo científico publicado en 2019

Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk

scientific article published on 10 December 2018

Smoking cessation and outcome after ischemic stroke or TIA.

artículo científico publicado en 2017

Social support as a buffer to the psychological impact of stressful life events in women with breast cancer

article

Taking care of volunteers in a stroke trial: a new assisted-management strategy

artículo científico publicado en 2016

Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.

artículo científico publicado en 2017

The Impact of Empagliflozin on Obstructive Sleep Apnea, Cardiovascular, and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial

scientific article published on 01 October 2020

What do medical schools teach about women's health and gender differences?

artículo científico publicado en 2006

Lista de obras de

A Diagnostic Score for Insulin Resistance in Nondiabetic Patients with Ischemic Stroke or Transient Ischemic Attack

A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks.

Achievement of Guideline-Recommended Weight Loss Among Patients With Ischemic Stroke and Obesity

Adherence reporting in randomized controlled trials

Altruism as a reason for participation in clinical trials was independently associated with adherence

An Error in An Old Paper Illustrates the Need for Data/Code Archives - Author response

Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort

Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus

Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum

Clinical assessment of function among women with a recent cerebrovascular event: a self-reported versus performance-based measure

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF

Decline in physical performance among women with a recent transient ischemic attack or ischemic stroke: opportunities for functional preservation a report of the Women's Estrogen Stroke Trial

Diabetes prevention and cardiovascular complications

Disagreement between students and preceptors regarding the value of teaching behaviors for ambulatory care settings

Distance from Home to Research Center: A Barrier to In-Person Visits but Not Treatment Adherence in a Stroke Trial.

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy ⬇️

Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial

Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial

Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes

Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST).

Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone

Influence of race, clinical, and other socio-demographic features on trial participation

Is It Time to Change the Type 2 Diabetes Treatment Paradigm? No! Metformin Should Remain the Foundation Therapy for Type 2 Diabetes

Litigation seeking access to data from ongoing clinical trials: a threat to clinical research

Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis

Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable

Major risk factors for intracerebral hemorrhage in the young are modifiable

Medical students' assessment of education and training in women's health and in sex and gender differences

Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular disease

Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease

Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).

Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial

Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial

Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke

Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke

Reports of Lactic Acidosis Attributed to Metformin, 2015-2018

Response by Young et al to Letters Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".

Response to Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015-2018. Diabetes Care 2020;43:244-246

Response to Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684-1692.

Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial

Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk

Smoking cessation and outcome after ischemic stroke or TIA.

Social support as a buffer to the psychological impact of stressful life events in women with breast cancer

Taking care of volunteers in a stroke trial: a new assisted-management strategy

Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.

The Impact of Empagliflozin on Obstructive Sleep Apnea, Cardiovascular, and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial

What do medical schools teach about women's health and gender differences?